Providing anti-retroviral treatment did not achieve the ambition of ‘Joint united nations program on HIV/AIDS (UNAIDS) among HIV positive patient in Ethiopia’: a systematic review and meta-analysis

References

• 90–90-90: JUNPoHA. (2014). An ambitious treatment target to help end the AIDS epidemic. Geneva: Available from:http://www.unaids.org/sites/default/files/media_asset/90-90-90_en_0.pdf. Accessed January 16, 2019.
   Google Scholar
• Ali, J. H., & Yirtaw, T. G. (2019). Time to viral load suppression and its associated factors in a cohort of patients taking antiretroviral treatment in East Shewa zone, Oromiya, Ethiopia, 2018. BMC Infectious Diseases, 19(1), 1084. https://doi.org/10.1186/s12879-019-4702-z
   PubMed Web of Science ®Google Scholar
• Anude, C. J., Eze, E., Onyegbutulem, H. C., et al. (2013). Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria. BMC Infectious Diseases, 13(1), 113. https://doi.org/10.1186/1471-2334-13-113
   PubMedGoogle Scholar
• Arrivillaga, M., Martucci, V., Hoyos, P. A., & Arango, A. (2013). Adherence among children and young people living with HIV/AIDS: A systematic review of medication and comprehensive interventions. Vulnerable Children and Youth Studies, 8(4), 321–337. https://doi.org/10.1080/17450128.2013.764031
   Google Scholar
• Atnafu, G. T., Moges, N. A., Wubie, M., & Gedif, G. (2022). Incidence and predictors of viral load suppression after enhanced adherence counseling among HIV-positive adults in West Gojjam Zone, Amhara Region, Ethiopia. Infection and Drug Resistance, Downloaded from https://www.dovepress.com/ on July 18, 2022 For personal use only.
   PubMed Web of Science ®Google Scholar
• Baggaley, R., Dalal, S., Johnson, C., Macdonald, V., Mameletzis, I., Rodolph, M., et al. (2016). Beyond the 90-90-90: Refocusing HIV prevention as part of the global HIV response. Journal of the International AIDS Society, DHHS. Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents. AIDS info 2017. https://doi.org/10.7448/IAS.19.1.21348
   Web of Science ®Google Scholar
• Ballesteros-Zebadúa, P. (2013). Differences in HIV- 1 viral load between males and females antiretroviral- untreated Mexican patients. Archives of Medical Research, 44(4), 296–301. https://doi.org/10.1016/j.arcmed.2013.04.003
   PubMed Web of Science ®Google Scholar
• Bello, E. J. M., Correia, A. F., Marins, J. R. P., Merchan-Hamann, E., et al. (2008). Predictors of virologic failure in HIV/AIDS patients treated with highly active antiretroviral therapy in Brasília, Brazil during 2002–2008. Drug Target Insights, 33–41.
   Google Scholar
• Boullé, C., et al. (2016). Virologic failure and human immunodeficiency virus drug resistance in rural Cameroon about the UNAIDS 90-90-90 treatment targets. Open Forum Infectious Diseases, 3(4), https://doi.org/10.1093/ofid/ofw233
   PubMedGoogle Scholar
• Bulage, L., et al. (2017). Factors associated with virological non-suppression among HIV-positive patients on antiretroviral therapy in Uganda, August 2014–July 2015. BMC Infectious Diseases, 17(1), 326, 032017. https://doi.org/10.1186/s12879-017-2428-3
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. (2018). Evidence of HIV treatment and viral suppression in preventing the sexual transmission of HIV. Department of Health & Human Services.
   Google Scholar
• Chao, C., Tang, B., Hurley, L., et al. (2012). Risk factors for short-term virologic outcomes among HIV-infected patients undergoing regimen switch of combination antiretroviral therapy. AIDS Research and Human Retroviruses, 28(12), 1630–1636. https://doi.org/10.1089/aid.2012.0005
   PubMed Web of Science ®Google Scholar
• Church, J. D., Omer, S. B., Guay, L. A., Huang, W., Lidstrom, J., Musoke, P., et al. (2008). Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV-infected despite receiving single dose (SD) nevirapine (NVP) vs. SD NVP plus daily NVP up to 6-weeks of age to prevent HIV vertical transmission. Journal of Infectious Diseases, 198(7), 1075–1082. https://doi.org/10.1086/591503
   PubMed Web of Science ®Google Scholar
• Das, M., Chu, P. L., Santos, G. M., et al. (2010). Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One, 5(6), e11068. https://doi.org/10.1371/journal.pone.0011068
   PubMed Web of Science ®Google Scholar
• Dires, Y. M. (2021). Virological non-suppression and associated factors among adolescents and youth living with HIV in Ethiopia. November 16, 2021. https://doi.org/10.21203/rs.3.rs-1014693/v1
   Google Scholar
• Diress, G., Dagne, S., Alemnew, B., Adane, S., & Addisu, A. (2020). Viral load suppression after enhanced adherence counseling and its predictors among high viral load HIV seropositive people in north wollo zone public hospitals, Northeast Ethiopia, 2019: Retrospective cohort study. Aids Research and Treatment, 2020, 1–9. https://doi.org/10.1155/2020/8909232
   Web of Science ®Google Scholar
• Drain, P. K., et al. (2019). Point-of-care HIV viral load testing: An essential tool for a sustainable global HIV/AIDS response. Clinical Microbiology Reviews, 32(3), 19. https://doi.org/10.1128/CMR.00097-18
   Web of Science ®Google Scholar
• Edessa, D., Sisay, M., & Asefa, F. (2019). Second-line HIV treatment failure in sub-saharan Africa: A systematic review and meta-analysis. PLoS One, 14(7), e0220159. https://doi.org/10.1371/journal.pone.0220159
   PubMed Web of Science ®Google Scholar
• Fenta, D. A., Wube, T. B., & Nuru, M. M. (2021). Long-term immunological and virological outcomes in children receiving highly active antiretroviral therapy at hawassa university college of medicine and health sciences, Southern Ethiopia. Journal of Immunology Research, 2021(Article ID 2498025), 9. https://doi.org/10.1155/2021/2498025
   Google Scholar
• Flynn, A. G., Anguzu, G., Mubiru, F., et al. (2017). Socioeconomic position and ten-year survival and virologic outcomes in a Ugandan HIV cohort receiving antiretroviral therapy. PLoS One, 12(12), e0189055. https://doi.org/10.1371/journal.pone.0189055
   PubMed Web of Science ®Google Scholar
• Germanaud, D., Derache, A., Traore, M., et al. (2009). Level of viral load and antiretroviral resistance after 6 months of nonnucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali. Journal of Antimicrobial Chemotherapy, 65(1), 118–124. https://doi.org/10.1093/jac/dkp412
   Web of Science ®Google Scholar
• Getachew, D., Eshetie, A., & Chekole, D. M. (2021). Modeling the long-term change of viral load of HIV positive patients on antiretroviral therapy. Cogent Medicine, 8(1), 2008607. https://doi.org/10.1080/2331205X.2021.2008607
   Google Scholar
• Getaneh, Y., Yizengaw, A., Likie, A., Getahun, M., Feleke, A., Kidane, E., … Assefa, Y. (2019). Rate and predictors of treatment failure among pediatric population taking highly active antiretroviral therapy in Ethiopia. medRxiv, 1–15.
   Google Scholar
• Haile, T., Hawulte, B., & Alemayehu, S. (2021). A retrospective cross-sectional study on the prevalence and factors associated with virological non-suppression among HIV-positive adult patients on antiretroviral therapy in woliso town, Oromia, Ethiopia. World Academy of Science, Engineering and Technology International Journal of Medical and Health Sciences, 15(4), 1–7.
   Google Scholar
• Hailemariam, S., Bune, G. T., & Ayele, H. T. (2013). Malnutrition: Prevalence and its associated factors in people living with HIV/AIDS: In dilla university referral hospital. Archives of Public Health, 71(1), 13. https://doi.org/10.1186/0778-7367-71-13
   PubMedGoogle Scholar
• HAPCO/EPHI. (2017). HIV epidemic estimates 2017–2021. EPHI. cited 2019 1/12/2019. 2019].
   Google Scholar
• Health. FMo. (2017). National guidelines for comprehensive HIV prevention, care, and treatment. Available from: https://aidsfree.usaid.gov/sites/default/files/resources/ethiopia_art_guidelines_2017.pdf. Accessed January 16, 2019.
   Google Scholar
• Hicham, T., Ilyas, E., Tarik, H., et al. (2019). Risk factors associated with unsuppressed viral load in HIV-1 infected patients at the first antiretroviral therapy in Morocco. International Journal of Mycobacteriology, 8(2), 113. https://doi.org/10.4103/ijmy.ijmy_41_19
   PubMed Web of Science ®Google Scholar
• Huibers, M. H., Moons, P., Cornelissen, M., Zorgdrager, F., Maseko, N., Gushu, M. B., et al. (2018). High prevalence of virological failure and HIV drug mutations in a first-line cohort of Malawian children. Journal of Antimicrobial Chemotherapy, 73(12), 3471–3475. https://doi.org/10.1093/jac/dky348
   PubMed Web of Science ®Google Scholar
• Hull, M. W., & Montaner, J. (2011). Antiretroviral therapy: A key component of a comprehensive HIV prevention strategy. Current HIV/AIDS Reports, 8(2), 85–93. https://doi.org/10.1007/s11904-011-0076-6
   PubMedGoogle Scholar
• Jean Louis, F., Buteau, J., François, K., et al. (2018). Virologic outcome among patients receiving antiretroviral therapy at five hospitals in Haiti. PLoS One, 13(1), e0192077. https://doi.org/10.1371/journal.pone.0192077
   PubMed Web of Science ®Google Scholar
• Jobanputra, K., Parker, L. A., Azih, C., et al. (2015). Factors associated with virological failure and suppression after enhanced adherence counseling, in children, adolescents, and adults on antiretroviral therapy for HIV in Swaziland. PLoS One, 10(2), e0116144. https://doi.org/10.1371/journal.pone.0116144
   PubMed Web of Science ®Google Scholar
• Jorge, A. R., Jorge, P., Elsa, G. L., et al. (2013). Risk factors associated with virologic failure in HIV-infected patients receiving antiretroviral therapy at a public hospital in Peru. Revista Chilena de Infectologia, 30(1), 42. https://doi.org/10.4067/S0716-10182013000100006
   PubMed Web of Science ®Google Scholar
• Joseph Davey, D., Abrahams, Z., Feinberg, M., et al. (2018). Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral therapy in South Africa. International Journal of STD & AIDS, 29(6), 603–610. https://doi.org/10.1177/0956462417748859
   PubMed Web of Science ®Google Scholar
• Kipp, W., Alibhai, A., Saunders, L. D., et al. (2010). Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda. AIDS Care, 22(3), 271–278. https://doi.org/10.1080/09540120903193625
   PubMed Web of Science ®Google Scholar
• Mehari, E., Muche, E. A., & Gonete, K. A. (2021). Virological suppression and its associated factors of dolutegravir based regimen in a resource-limited setting: An observational retrospective study in Ethiopia. HIV/AIDS – Research and Palliative Care. Downloaded from https://www.dovepress.com/ by 197.156.120.25 on 01-Oct-2021.
   Google Scholar
• Meireles, M. V., Pascom, A. R. P., & Duarte, E. C. (2018). Factors associated with early virological response in HIV-infected individuals starting antiretroviral therapy in Brazil (2014–2015): Results from a large HIV surveillance cohort. Journal of Acquired Immune Deficiency Syndromes, 78(4), e19. https://doi.org/10.1097/QAI.0000000000001684
   PubMed Web of Science ®Google Scholar
• MoHo. (2019). E. National guidelines for comprehensive HIV prevention care and treatment, 2019. Addis Ababa.
   Google Scholar
• Moolasart, V., Chottanapund, S., Ausavapipit, J., Likanonsakul, S., Uttayamakul, S., Changsom, D., et al. (2018). The effect of detectable HIV viral load among HIV-infected children during antiretroviral treatment: A cross-sectional study. Children, 5(6), 1–9.
   Google Scholar
• Muri, L., Gamell, A., Ntamatungiro, A. J., et al. (2017). Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania. Aids (London, England), 31(1), 61–70. https://doi.org/10.1097/QAD.0000000000001273
   PubMed Web of Science ®Google Scholar
• Nabitaka, V. M., Nawaggi, P., Campbell, J., et al. (2020). High acceptability and viral suppression of patients on dolutegravir-based first-line regimens in pilot sites in Uganda: A mixed-methods prospective cohort study. PLoS One, 15(5), e0232419. https://doi.org/10.1371/journal.pone.0232419
   PubMed Web of Science ®Google Scholar
• Nelson, L. J., Beusenberg, M., Habiyambere, V., et al. (2014). Adoption of national recommendations related to the use of antiretroviral therapy before and shortly following the launch of the 2013 WHO consolidated guidelines. Aids (London, England), 28, S217–S224. https://doi.org/10.1097/QAD.0000000000000239
   PubMed Web of Science ®Google Scholar
• PEPFAR. (2019). The global HIV/AIDS epidemic; 2019. Available from: https://www.hiv.gov/hiv-basics/overview/data-and-trends/globalstatistics. Accessed July 07, 2020.
   Google Scholar
• PTRoSRaM-A. (2021). [Internet]. cited November 18, 2021. http://www.prisma-statement.org/PRISMAStatement/Checklist.aspx.
   Google Scholar
• Rangarajan, S., Colby, D. J., Bui, D. D., Nguyen, H. H., Tou, P. B., et al. (2016). Factors associated with HIV viral load suppression on ART in Vietnam. Journal of Virus Eradication, 2(2), 94–101. https://doi.org/10.1016/S2055-6640(20)30466-0
   PubMed Web of Science ®Google Scholar
• Sabaté, E. (2003). Adherence to long-term therapies: Evidence for action. World Health Organization.
   Google Scholar
• Schoffelen, A. F., Wensing, A. M., Tempelman, H. A., Geelen, S. P., Hoepelman, A. I., & Barth, R. E. (2013). Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa. PLoS One, 8(3), https://doi.org/10.1371/journal.pone.0058526
   Web of Science ®Google Scholar
• Shiferaw, M. B., Endalamaw, D., Hussien, M., Agegne, M., Amare, D., Estifanos, F., & Temesgen, D. (2019). Viral suppression rate among children tested for HIV viral load at the Amhara public health institute, Bahir Dar, Ethiopia. BMC Infectious Diseases, 19(1), 419. https://doi.org/10.1186/s12879-019-4058-4
   PubMedGoogle Scholar
• Stover, J., Bollinger, L., Izazola, J. A., Loures, L., DeLay, P., & Ghys, P. D. (2016). Fast. Track modeling working group. What is required to end the AIDS epidemic as a public health threat by 2030? The cost and impact of the fast-track approach. PLoS One, 11(5), e0154893. https://doi.org/10.1371/journal.pone.0154893
   PubMed Web of Science ®Google Scholar
• Sylla, M., et al. (2019 July). Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in Mali. Archives de Pediatrie, 26(5), 254–258. https://doi.org/10.1016/j.arcped.2019.06.002
   PubMed Web of Science ®Google Scholar
• UNAIDS. (2016). The need for routine viral load testing.
   Google Scholar
• UNAIDS. (2017). 90-90-90 an ambitious treatment target to help end the AIDS epidemic.
   Google Scholar
• UNAIDS. (2021). A collaboration of UNAIDS UaW. Global factsheets AIDSinfo; 2011.
   Google Scholar
• UNAIDS JUNPoHA. (2019). 90–90-90: An ambitious treatment target to help end the AIDS epidemic. Geneva, 2014, http://www.unaids.org/sites/default/files/media_asset/90-90-90_en_0.pdf. Accessed.
   Google Scholar
• Waju, B., Dube, D., Muktar, A., & Semira, S. (2021). Unsuppressed viral load level in public health facilities: Nonvirological predictors among adult antiretroviral therapy users in Southwestern Ethiopia. HIV/AIDS – Research and Palliative Care, downloaded from https://www.dovepress.com/ by 197.156.120.25 on October 01, 2021.
   Google Scholar
• Wells, G. A., Shea, S., O’Connell, D., Peterson, J., Welch, V., Losos, M., et al. (2000). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses [Internet]. cited 1BC Feb 1. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
   Google Scholar
• WHO. (2016). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach.
   Google Scholar
• WHO. (2017). Adapting and implementing new recommendations on HIV patient monitoring. World Health Organization.
   Google Scholar
• WHO. (2019). Global health observatory data on the prevalence of HIV among adults aged 15–49. 2017.
   Google Scholar
• Zealiyas, K. (2020). STD & HIV/AIDS 2018: Viral load suppression status and associated factors among patient on antiretroviral treatment in Ethiopia – Kidist Zealiyas – Ethiopian public health institute. Ethiopia, 6(2), 1–7.
   Google Scholar